BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 12697682)

  • 1. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
    Frost RA; Nystrom GJ; Lang CH
    Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C(2)C(12) myoblasts via Toll-like receptor-4 and c-Jun NH(2)-terminal kinase pathways.
    Frost RA; Nystrom GJ; Lang CH
    Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1605-15. PubMed ID: 15282190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.
    Frost RA; Nystrom GJ; Lang CH
    Endocrinology; 2002 Feb; 143(2):492-503. PubMed ID: 11796503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase.
    Frost RA; Nystrom GJ; Lang CH
    Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R1153-64. PubMed ID: 12842862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
    Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
    Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha.
    Fernández-Celemín L; Pasko N; Blomart V; Thissen JP
    Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1279-90. PubMed ID: 12388149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
    Thissen JP; Verniers J
    Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle.
    Frost RA; Nystrom GJ; Lang CH
    Am J Physiol Regul Integr Comp Physiol; 2002 Sep; 283(3):R698-709. PubMed ID: 12185005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
    Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to TNF-alpha but not IL-1beta impairs insulin-dependent phosphorylation of protein kinase B and p70S6k in mouse C2C12 myogenic cells.
    Grzelkowska-Kowalczyk K; Wieteska-Skrzeczyńska W
    Pol J Vet Sci; 2006; 9(1):1-10. PubMed ID: 16573269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression.
    Ge X; Yu J; Jiang H
    J Anim Sci; 2012 Apr; 90(4):1126-33. PubMed ID: 22100600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis.
    Frost RA; Lang CH; Gelato MC
    Endocrinology; 1997 Oct; 138(10):4153-9. PubMed ID: 9322924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis.
    Yumet G; Shumate ML; Bryant P; Lin CM; Lang CH; Cooney RN
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E472-81. PubMed ID: 12169440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
    Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells and in C2C12 myoblasts. A central role of protein kinase Cdelta.
    Czifra G; Tóth IB; Marincsák R; Juhász I; Kovács I; Acs P; Kovács L; Blumberg PM; Bíró T
    Cell Signal; 2006 Sep; 18(9):1461-72. PubMed ID: 16403461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
    Wu GJ; Chen TL; Ueng YF; Chen RM
    Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of somatotropic function by proinflammatory cytokines.
    Frost RA; Lang CH
    J Anim Sci; 2004; 82 E-Suppl():E100-109. PubMed ID: 15471789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
    Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.
    Strle K; Broussard SR; McCusker RH; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2004 Oct; 145(10):4592-602. PubMed ID: 15256490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.